Cancer.gov reports that the FDA has expanded the approved uses for nivolumab, an immunotherapy drug. It can now be used to treat patients with some melanomas and lung cancers. Please see the article for the details. http://www.cancer.gov/news-events/cancer-currents-blog/2015/nivolumab-expanded